Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Aurélie MéneretShekeeb S MohammadLaura CifDiane DoummarClaudio M De GusmaoMathieu AnheimMagalie BarthPhilippe DamierNathalie DemonceauJennifer FriedmanCécile GalleaDomitille GrasJuliana Gurgel-GiannettiEmily A InnesJán NecpálFlorence RiantSandrine SagnesCatherine SarretYury SeliverstovVijayashankar ParamanandamKuldeep ShettyChristine TranchantMohamed DoulazmiMarie VidailhetTamara M PringsheimEmmanuel RozePublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
Our findings suggest that caffeine should be considered as a first-line therapeutic option in ADCY5-related dyskinesia. © 2022 International Parkinson and Movement Disorder Society.
Keyphrases